Analysen von Graham Parry
| 13.09.19 | GSK Neutral | Merrill Lynch & Co., Inc. | |
| 06.12.17 | GSK Neutral | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Sanofi Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Sanofi Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 07.07.14 | Novartis Neutral | Merrill Lynch & Co., Inc. |